Clinical Trial Update: Paediatric Ards Neuromuscular Blockade Study [Phase 4]

View source ↗

Summary

A Phase 4 pediatric acute respiratory distress syndrome trial evaluating a neuromuscular blockade agent has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Snippet

Sponsor: University Medical Center Groningen | Conditions: ARDS | Phase 4 | Status: TERMINATED